Pfizer faces a lawsuit in which women allege the drugmaker failed to warn them about the risks of meningioma associated with ...
Pfizer’s mRNA flu vaccine outperformed the standard flu shot in a Phase 3 clinical trial, according to results published Wednesday in the New England Journal of Medicine. The vaccine uses the same ...
Final analysis: Pfizer's COVID-19 vaccine 95% effective, company to seek authorization within 'days'
A final analysis of a COVID-19 vaccine candidate produced by Pfizer and BioNTech shows that the drug is 95% effective in preventing the coronavirus, and the companies say they hope to apply for ...
WASHINGTON (Nexstar) — The former president of the American Academy of Pediatrics said it’s important to vaccinate kids 12-and-older now that the Pfizer COVID vaccine is approved for that age group.
Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. Of 9,225 ...
Pfizer Australia and BioNTech have welcomed the TGA's move to register the companies' new COVID-19 vaccine into its public ...
An infectious disease specialist at Duke University Hospital is one of the 44,000 people enrolled in Pfizer's clinical trials of a potential coronavirus vaccine. An infectious disease specialist at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback